Share

Sanofi CEO says Dupixent eczema drug is game-changing for company

"This is a once in a generation medicine," Sanofi CEO Paul Hudson said of Dupixent, a therapy for allergic diseases such as eczema, asthma and nasal polyps that's seeing rapid sales growth.
02:46
Fri, Feb 5 20217:25 PM EST